This case highlights the necessity of detecting GPIHBP1 autoantibodies in patients with acquired hypertriglyceridemia.
Supports GPIHBP1 autoantibody testing in unexplained acquired hypertriglyceridemia; leaves open prevalence and management questions.
We report a case of a woman with primary hypertriglyceridemia caused by acquired glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 (GPIHBP1) autoantibody. This case highlights the necessity of detecting GPIHBP1 autoantibody in patients with acquired hypertriglyceridemia. (Level of Difficulty: Intermediate.)
No takes yet. Share an insight, caveat, or question.
Hirano et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: